[Non-invasive ventilation in children: Do we need more evidence?]

Area of Science:

• Pediatric critical care medicine
• Respiratory medicine
• Mechanical ventilation

Background:

• Respiratory failure is a primary cause of pediatric intensive care unit (PICU) admissions, linked to high morbidity and mortality.
• Non-invasive ventilation (NIV) is the preferred initial treatment for respiratory failure, aiming to decrease endotracheal intubation rates.
• Despite increasing use in PICUs, research on NIV's efficacy and optimal application remains limited.

Purpose of the Study:

• To review the primary indications for NIV in acute pediatric settings.
• To synthesize current evidence and expert opinion on NIV use across various respiratory conditions.
• To highlight areas where NIV efficacy is well-established versus those requiring further investigation.

Main Methods:

• Literature review of studies on non-invasive ventilation in pediatric acute care.
• Synthesis of data from descriptive studies, expert opinions, and available randomized trials.
• Identification and categorization of key indications for NIV in the PICU.

Main Results:

• NIV is indicated for conditions including bronchiolitis, postextubation respiratory failure, acute respiratory distress syndrome, pneumonia, status asthmaticus, and others.
• Evidence supporting NIV varies by indication; benefits are clear in bronchiolitis but less certain in other conditions.
• Most current data relies on observational studies and expert consensus, with a scarcity of randomized controlled trials.

Conclusions:

• NIV is a valuable tool in pediatric respiratory failure management, with proven benefits in specific conditions like bronchiolitis.
• Careful patient selection and monitoring for NIV failure are essential for optimizing outcomes.
• Further high-quality research, particularly randomized trials, is needed to clarify NIV's role in various pediatric respiratory conditions.